百洋医药:与杰特贝林再度携手，布局中国血液制品赛道

财经网2025-11-05

11月4日，青岛百洋医药股份有限公司发布公告称，公司与全球生物技术巨头、血液制品领导者杰特贝林（CSL）签订深化合作协议。根据协议，百洋医药将获得杰特贝林旗下人血白蛋白产品安博美在中国大陆地区的独家推广、销售和经销权益。公告提到，百洋医药自 2021 年 3 月与杰特贝林就人血白蛋白产品安博美的零售市场开展合作，本次签署《经销协议》，将合作市场拓展至区域内特定的零售市场、广阔市场、医院市场（君信...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2581712271?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-11-05 00:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2581712271","market":"us","top_or_hot":-1,"title":"百洋医药:与杰特贝林再度携手，布局中国血液制品赛道","media":"财经网","content":"<div>\n<p>11月4日，青岛百洋医药股份有限公司发布公告称，公司与全球生物技术巨头、血液制品领导者杰特贝林（CSL）签订深化合作协议。根据协议，百洋医药将获得杰特贝林旗下人血白蛋白产品安博美在中国大陆地区的独家推广、销售和经销权益。公告提到，百洋医药自 2021 年 3 月与杰特贝林就人血白蛋白产品安博美的零售市场开展合作，本次签署《经销协议》，将合作市场拓展至区域内特定的零售市场、广阔市场、医院市场（君信...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105003503a4884670&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>百洋医药:与杰特贝林再度携手，布局中国血液制品赛道</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n百洋医药:与杰特贝林再度携手，布局中国血液制品赛道\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-05 00:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105003503a4884670&s=b><strong>财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>11月4日，青岛百洋医药股份有限公司发布公告称，公司与全球生物技术巨头、血液制品领导者杰特贝林（CSL）签订深化合作协议。根据协议，百洋医药将获得杰特贝林旗下人血白蛋白产品安博美在中国大陆地区的独家推广、销售和经销权益。公告提到，百洋医药自 2021 年 3 月与杰特贝林就人血白蛋白产品安博美的零售市场开展合作，本次签署《经销协议》，将合作市场拓展至区域内特定的零售市场、广阔市场、医院市场（君信...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105003503a4884670&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4171","symbol_name":"工业房地产投资信托","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105003503a4884670&s=b","article_id":"2581712271","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105003503a4884670&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2581712271","pubTimestamp":1762273867,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"11月4日，青岛百洋医药股份有限公司发布公告称，公司与全球生物技术巨头、血液制品领导者杰特贝林签订深化合作协议。根据协议，百洋医药将获得杰特贝林旗下人血白蛋白产品安博美在中国大陆地区的独家推广、销售和经销权益。公告提到，百洋医药自 2021 年 3 月与杰特贝林就人血白蛋白产品安博美的零售市场开展合作，本次签署《经销协议》，将合作市场拓展至区域内特定的零售市场、广阔市场、医院市场，进一步深化双方的合作。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4171":"工业房地产投资信托","BK4224":"工业房地产信托","LU1169590202.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"I\" (USD) ACC","PLD":"安博","BK4588":"碎股","SG9999004303.SGD":"Nikko AM Shenton Global Opportunities SGD","LU0728928796.USD":"abrdn SICAV I - GLOBAL SMALL&MID-CAP SDG HORIZONS EQUITY \"A\" (USD) ACC","SGXZ23171101.USD":"NIKKO AM SHENTON GLOBAL OPPORTUNITIES (USD) ACC","LU1169589451.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"A\" (USD) ACC","BK4086":"建筑产品","BK4585":"ETF&股票定投概念","BK4567":"ESG概念","CSL":"卡莱尔伙伴","BK4534":"瑞士信贷持仓"},"translate_title":"Baheal Pharmaceuticals: Join hands with Jetbelin again to lay out China's blood products track","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PLD":0.76,"CSL":1},"content_text":"11月4日，青岛百洋医药股份有限公司发布公告称，公司与全球生物技术巨头、血液制品领导者杰特贝林（CSL）签订深化合作协议。根据协议，百洋医药将获得杰特贝林旗下人血白蛋白产品安博美在中国大陆地区的独家推广、销售和经销权益。公告提到，百洋医药自 2021 年 3 月与杰特贝林就人血白蛋白产品安博美的零售市场开展合作，本次签署《经销协议》，将合作市场拓展至区域内特定的零售市场、广阔市场、医院市场（君信提供清单的除外），进一步深化双方的合作。安博美是杰特贝林专为中国市场设计生产, 其核心差异化优势在于可支持在不超过30℃的条件下常温避光储存，大幅降低了对复杂冷链物流的依赖，显著提升用药可及性与供应链韧性。公司取得了在中国（不包括香港、澳门及台湾地区）区域内特定市场对安博美的独家推广、销售和经销的权益，将为安博美提供商业化整体解决方案，助力产品可及并释放品牌价值，推动产品精准适配应用场景。本次深度合作是杰特贝林对公司专业商业化能力认可的体现，有助于公司丰富品类矩阵，提高公司的品牌影响力和市场竞争力。（百洋医药公告）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2581712271","isCrawlerRequest":true}